Mirion Technologies, Inc. designs, manufactures, and delivers radiation detection, measurement, analysis, and monitoring products to nuclear power, medical, military, and homeland security markets. It offers personnel exposure monitoring and access control systems that include radiation detectors for handheld measurement; contamination and clearance products; wireless monitoring products; advanced detection and isotope identification products; and radiation area monitoring systems. The company also provides radiation tolerant cameras, high temperature imaging systems, and video image processing and accessories; and reactor control and protection, containment, effluent release monitoring, operational process monitoring, and area monitoring systems. In addition, it offers radiation monitoring services and dosimetry solutions for a range of applications; and nuclear sensing instrumentation and sealing systems that include in-core detectors, ex-core detectors, reactor neutron and gamma detector instruments, nuclear containment seals, and severe accident lines. Mirion Technologies, Inc. designs, manufactures, and delivers radiation detection, measurement, analysis, and monitoring products to nuclear power, medical, military, and homeland security markets. It offers personnel exposure monitoring and access control systems that include radiation detectors for handheld measurement; contamination and clearance products; wireless monitoring products; advanced detection and isotope identification products; and radiation area monitoring systems. The company also provides radiation tolerant cameras, high temperature imaging systems, and video image processing and accessories; and reactor control and protection, containment, effluent release monitoring, operational process monitoring, and area monitoring systems. In addition, it offers radiation monitoring services and dosimetry solutions for a range of applications; and nuclear sensing instrumentation and sealing systems that include in-core detectors, ex-core detectors, reactor neutron and gamma detector instruments, nuclear containment seals, and severe accident lines. It also offers service, such as measurement, installation, product support and repairs, and consulting services. The company serves customers in nuclear power plants, military and civil defense agencies, hospitals, universities, national labs, and other specialized industries. Mirion Technologies, Inc. was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in San Ramon, California with facilities in Europe, Asia, and North America. The company serves customers in nuclear power plants, military and civil defense agencies, hospitals, universities, national labs, and other specialized industries. Mirion Technologies, Inc. was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in San Ramon, California with facilities in Europe, Asia, and North America.
IPO Year: 2020
Exchange: NYSE
Website: mirion.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/19/2024 | $22.00 | Outperform | Robert W. Baird |
| 9/26/2024 | $14.00 | Buy | B. Riley Securities |
| 5/26/2023 | $11.00 | Buy | Citigroup |
| 3/24/2022 | $13.00 | Market Outperform | CJS Securities |
| 11/29/2021 | $14.00 | Buy | Goldman Sachs |
| 10/25/2021 | $14.00 | Buy | Citigroup |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4/A - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
4 - Mirion Technologies, Inc. (0001809987) (Issuer)
Fastest customizable press release news feed in the world
Revenue for the second quarter increased 7.6% to $222.9 million, compared to $207.1 million in the same period in 2024. GAAP net income was $8.5 million in the second quarter, compared to a GAAP net loss of $12.0 million in the same period in 2024; a 171% improvement. Adjusted EBITDA was $51.2 million in the second quarter, a 4.9% increase from $48.8 million in the same period in 2024. GAAP net earnings per share in the second quarter was $0.04, compared to a GAAP net loss per share of $0.06 in the same period in 2024. Adjusted earnings per share for the quarter was $0.11, compared to $0.10 in the same period in 2024. The company raised guidance for total Revenue growth, Adjusted
The acquisition strengthens Mirion's position across nuclear power facilities and supports commitment to safely meeting rising global energy demand. Mirion (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry. Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply. Since 1988, Certrec's innovation and industry expertise has helped hundreds of power-generating facilities reduce risk an
Mirion (NYSE:MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with ac
Based on Mirion's proTK™ Product Line, the Newly Designed Solution Aims to Reduce Burden and Enhance Performance in Nuclear Power Plants. Mirion Technologies (NYSE:MIR), a leading provider of advanced radiation safety solutions, and Westinghouse Electric Company LLC, a leading supplier of nuclear plant instrumentation and control systems, have announced a strategic partnership to provide digital Ex-core Nuclear Instrumentation Systems (NIS) based on the high-performing Mirion proTK product line. This collaboration aims to alleviate operator and maintenance burdens, enhance performance, and ensure sustained operation success. This digital NIS upgrade solution is offered exclusively through
Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced the pricing of $350.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2030 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The size of the Offering was increased from the previously announced $300.0 million aggregate principal amount of Notes. In connection with the Offering, Mirion granted the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first is
Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced its intent to offer $300.0 million aggregate principal amount of Convertible Senior Notes due 2030 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Mirion also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $45.0 million aggregate principal amount of Notes. The Offering is subject to market and other conditions, and there
Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA
Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces
Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality Mirion Technologies (NYSE:MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces the Mirion commitment to improving quality in cancer care, through focused innovation across its Mirion Technologies and Mi
Mirion selected to supply Radiation Monitoring System (RMS) and Nuclear Instrumentation System (XIS) for advanced nuclear reactor project. Mirion (NYSE:MIR), a global leader in radiation safety, science, and medicine, has been selected to supply the Radiation Monitoring System (RMS) and Nuclear Instrumentation System (XIS) to support the Natrium Reactor Demonstration Project in Wyoming. This project marks the first commercial advanced nuclear power plant in the U.S. and is a public-private partnership between TerraPower, a leading nuclear innovation company, and the U.S. Department of Energy (DOE). The goal is to deploy the Natrium technology, which combines a sodium-cooled fast reactor wi
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Robert W. Baird initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $22.00
B. Riley Securities initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00
Citigroup resumed coverage of Mirion Technologies with a rating of Buy and set a new price target of $11.00
CJS Securities initiated coverage of Mirion Technologies with a rating of Market Outperform and set a new price target of $13.00
Goldman Sachs initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00
Citigroup initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00
144 - Mirion Technologies, Inc. (0001809987) (Subject)
10-Q - Mirion Technologies, Inc. (0001809987) (Filer)
8-K - Mirion Technologies, Inc. (0001809987) (Filer)
8-K - Mirion Technologies, Inc. (0001809987) (Filer)
SD - Mirion Technologies, Inc. (0001809987) (Filer)
8-K - Mirion Technologies, Inc. (0001809987) (Filer)
8-K - Mirion Technologies, Inc. (0001809987) (Filer)
144 - Mirion Technologies, Inc. (0001809987) (Subject)
144 - Mirion Technologies, Inc. (0001809987) (Subject)
8-K - Mirion Technologies, Inc. (0001809987) (Filer)
Live Leadership Updates
SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail
Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control
Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le
Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Dr. Sheila Rege, M.D. has been appointed to the Board of Directors, replacing Mr. Christopher Warren, who is stepping down. Lawrence D. Kingsley, Chairman of Mirion's Board of Directors said, "I am pleased to welcome Sheila to Mirion's Board of Directors. She brings deep experience and a long track record of accomplishment in nuclear medicine and radiation oncology to Mirion's Board. We are excited to have Sheila join us and believe that her diverse sk
Live finance-specific insights
Revenue for the second quarter increased 7.6% to $222.9 million, compared to $207.1 million in the same period in 2024. GAAP net income was $8.5 million in the second quarter, compared to a GAAP net loss of $12.0 million in the same period in 2024; a 171% improvement. Adjusted EBITDA was $51.2 million in the second quarter, a 4.9% increase from $48.8 million in the same period in 2024. GAAP net earnings per share in the second quarter was $0.04, compared to a GAAP net loss per share of $0.06 in the same period in 2024. Adjusted earnings per share for the quarter was $0.11, compared to $0.10 in the same period in 2024. The company raised guidance for total Revenue growth, Adjusted
The acquisition strengthens Mirion's position across nuclear power facilities and supports commitment to safely meeting rising global energy demand. Mirion (NYSE:MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry. Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply. Since 1988, Certrec's innovation and industry expertise has helped hundreds of power-generating facilities reduce risk an
Mirion (NYSE:MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with ac
Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA
Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces
Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece
Mirion (NYSE:MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until February 26, 2025. Participants may access the replay at 1-844-512-2921
Revenues for the third quarter increased 8.2% to $206.8 million, compared to $191.2 million in the same period in 2023. Net loss was $14.0 million in the third quarter, compared to a net loss of $12.9 million in the same period last year. Adjusted EBITDA was $45.7 million, a 17.8% increase from $38.8 million in the same period last year. Loss from operations margin was 0.8% in the third quarter, compared to 5.8% in the same period in 2023. Adjusted EBITDA margin was 22.1% in the third quarter, compared to 20.3% in the same period last year. GAAP net loss per share for the third quarter was $0.07, compared to $0.06 in the third quarter of 2023. Adjusted earnings per share for the q
Mirion (NYSE:MIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until November 13, 2024. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 w
Revenues for the second quarter increased 5.0% to $207.1 million, compared to $197.2 million in the same period in 2023. Net loss was $12.0 million in the second quarter, compared to a net loss of $28.4 million in the same period last year. Adjusted EBITDA was $48.8 million, a 10.2% increase from $44.3 million in the same period last year. Income (loss) from operations margin was 1.1% in the second quarter, compared to (5.4)% in the same period in 2023. Adjusted EBITDA margin was 23.6% in the second quarter, compared to 22.5% in the same period last year. GAAP net loss per share for the second quarter was $0.06, compared to $0.14 in the second quarter of 2023. Adjusted earnings pe
This live feed shows all institutional transactions in real time.
SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13G - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13G - Mirion Technologies, Inc. (0001809987) (Subject)
SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)